OmniAb reported a robust first quarter in 2025 with increased revenue driven by milestone payments and higher license fees, alongside a reduced net loss due to lower operating expenses. The company also announced strategic initiatives like the xPloration® Partner Access Program and affirmed its 2025 financial guidance.
Revenue for Q1 2025 increased to $4.2 million from $3.8 million in Q1 2024, primarily due to a $1.0 million Phase 1 milestone payment and higher license fees.
Net loss for Q1 2025 decreased to $18.2 million, or $0.17 per share, compared to $19.0 million, or $0.19 per share, in Q1 2024.
Operating expenses decreased to $22.998 million in Q1 2025 from $26.354 million in Q1 2024, driven by lower R&D and G&A expenses.
OmniAb affirmed its 2025 revenue guidance of $20 million to $25 million and revised operating expense guidance to $85 million to $90 million.
OmniAb affirmed its 2025 revenue guidance and revised its operating expense guidance, while also expecting lower cash use compared to 2024.